6 development of new method and protocol for cryopreservation related to embryo and oocytes freezing in terms of fertilization rate: a comparative study including review of literature

7 medical image of the week: bronchial clot removal via cryotherapy

8 Foliar anthocyanin accumulation may be a useful indicator of hardiness in eucalypt seedlings

9 Potential drug-drug interactions of immunosuppressants in kidney transplant recipients: comparison of drug interaction resources

10 Face Transplantation and Identity: Hidden Identities, Exceptions, and Exclusions.

11 Acute Renal Transplant Failure Secondary to an Obstructing Ileal Conduit Adenocarcinoma: Case Report and Literature Review.

12 Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: Case report and review of the literature.

13 Why do lung transplant patients discontinue triazole prophylaxis?

14 Interventions to Prevent Nonmelanoma Skin Cancers in Recipients of a Solid Organ Transplant: Systematic Review of Randomized Controlled Trials.

15 Exercise training is safe and feasible in patients awaiting liver transplantation: a pilot randomized controlled trial.

16 Kidney transplantation from living donors with multiple renal arteries

17 Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology

18 Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt

19 Invasive pulmonary infection due to Thermoascus crustaceus in a kidney transplant recipient

20 Genetic diversity and antibiotic susceptibility of uropathogenic Escherichia coli isolates from kidney transplant recipients

21 Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

22 Comparative effectiveness of antifungal agents in patients with hematopoietic stem cell transplantation: a systematic review and network meta-analysis

23 Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy

24 Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]

25 Pseudomonas aeruginosa bacteremia among liver transplant recipients

26 Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation

27 Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

28 Methicillin-resistant Staphylococcus aureus bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality

29 Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

30 Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

31 Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt

32 Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

33 Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt

34 Invasive pulmonary infection due to Thermoascus crustaceus in a kidney transplant recipient

35 Genetic diversity and antibiotic susceptibility of uropathogenic Escherichia coli isolates from kidney transplant recipients

36 Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

37 Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt

38 Invasive pulmonary infection due to Thermoascus crustaceus in a kidney transplant recipient

39 Genetic diversity and antibiotic susceptibility of uropathogenic Escherichia coli isolates from kidney transplant recipients

40 Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

41 Pros and Cons of Aspirin Prophylaxis for Prevention of Cardiovascular Events in Kidney Transplantation and Review of Evidence

42 Dermatological Disorders following Liver Transplantation: An Update

43 The Effects of Fecal Donors with Different Feeding Patterns on Diarrhea in a Patient Undergoing Hematopoietic Stem Cell Transplantation

44 Comparative effectiveness of antifungal agents in patients with hematopoietic stem cell transplantation: a systematic review and network meta-analysis

45 Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy

46 Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]

47 Pseudomonas aeruginosa bacteremia among liver transplant recipients

48 Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation

49 Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

50 Methicillin-resistant Staphylococcus aureus bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality

51 Gastric Mucormycosis in a Renal Transplant Patient Treated with Isavuconazole Monotherapy

52 Postinfectious Acute Glomerulonephritis in Renal Transplantation: An Emergent Aetiology of Renal Allograft Loss

53 Unusual Presentation of Hemophagocytic Lymphohistiocytosis in a Kidney Transplant Patient

54 An Atypical Case of Shiga Toxin Producing-Escherichia Coli Hemolytic and Uremic Syndrome (STEC-HUS) in a Lung Transplant Recipient

55 Deceased Donor Renal Transplantation Combined with Bilateral Nephrectomy in a Patient with Tuberous Sclerosis and Renal Failure

56 The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis

57 Segmental Distribution of Hepatocellular Carcinoma Correlates with Microvascular Invasion in Liver Explants Undergoing Transplantation

58 Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

59 Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

60 Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt

61 Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

62 Vectisol Formulation Enhances Solubility of Resveratrol and Brings Its Benefits to Kidney Transplantation in a Preclinical Porcine Model.

63 Emerging therapeutic strategies for transplantation-induced acute kidney injury: protecting the organelles and the vascular bed.

64 Acute Kidney Injury in Pregnant Patient With Pancreas-Kidney Transplant Caused by Abdominal Compartment Syndrome: A Case Presentation, Review of Literature, and Proposal of Diagnostic Approach.

65 Heavy metal accumulation and phytoremediation potential by transplants of the seagrass Zostera marina in the polluted bay systems

66 Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.

67 Voriconazole tolerability in lung transplant recipients: Is N-oxide metabolite responsible for phototoxicity?

68 Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.

69 Negative impact of recipient SPRED2 deficiency on transplanted lung in a mouse model.

70 Randomized Controlled Trial Assessing the Impact of Everolimus and Low Exposure Tacrolimus on Graft Outcomes in Kidney Transplant Recipients.

71 Fecal metabolite of a gnotobiotic mouse transplanted with gut microbiota from a patient with Alzheimer's disease.

72 Human Herpesvirus 6B and Lower Respiratory Tract Disease After Hematopoietic Cell Transplantation.

73 Roles of Epstein–Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation

74 Challenging hepatitis C-infected liver transplant patients

75 Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT.

76 Management of Kaposi sarcoma after solid organ transplantation: A European retrospective study

77 Decreased incidence of Kaposi sarcoma after kidney transplant in Italy and role of mTOR-inhibitors: 1997–2016

78 Imaging of Kaposi sarcoma in a transplanted liver: A rare case report

79 Proactive treatment of angiotensin receptor antibodies in kidney transplantation with plasma exchange and/or candesartan is safe and associated with excellent graft survival at 4 years: A single centre Australian experience

80 Effects of telmisartan and candesartan on the metabolism of lipids and glucose in kidney transplant patients: A prospective, randomized crossover study

81 [Relation between renal transplantation and work situation].

82 Recent advances in understanding and managing infectious diseases in solid organ transplant recipients.

83 HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.

84 Incidence of and risk factors for cryptococcosis in kidney transplant recipients in Taiwan- a nationwide population-based study.

85 A novel automated transplanting system for plant tissue culture

86 Bone-Plug Versus Soft Tissue Fixation of Medial Meniscal Allograft Transplants: A Biomechanical Study.

87 Sex and Gender Considerations in Transplant Research: A Scoping Review.

88 Exercise for Solid Organ Transplant Candidates and Recipients: A Joint Position Statement of the Canadian Society of Transplantation and CAN-RESTORE.

89 Kidney transplantation. Experience at the University Hospital José E. González, UANL in Monterrey, Mexico

90 Application of Machine-Learning Models to Predict Tacrolimus Stable Dose in Renal Transplant Recipients.

91 Protocol-Based Nurse Coordinator Management of Ambulatory Tacrolimus Dosing in De Novo Renal Transplant Recipients - A Single Center Experience with a Large African American Population.

92 Predictors of Meniscal Allograft Transplantation Outcome: A Systematic Review.

93 Induction of Accommodation by Anti-complement Component 5 Antibody-based Immunosuppression in ABO-incompatible Heart Transplantation.

94 Defining the Burden of Emergency General Surgery in Transplant Patients: A Nationwide Examination

95 Combined Thoracic and Abdominal Organ Transplantation: Special Considerations.

96 Outcomes of Vascularized Bone Allotransplantation with Surgically Induced Autogenous Angiogenesis in a Large Animal Model: Bone Healing, Remodeling, and Material Properties.

97 Commentary on “FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study”

98 A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial.

99 Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing.

100 A randomized, non-inferiority study comparing efficacy and safety of a single dose of pegfilgrastim versus daily filgrastim in pediatric patients after autologous peripheral blood stem cell transplant.

101 Experimental small bowel transplantation from non-heart-beating donors: a large-animal study.

Keyword Connections

Journals

Research Groups

Bibliographies